Junshi Biosciences, Dr. Reddy's Partner To Develop Toripalimab In 21 Countries
Junshi Biosciences will grant a license to Dr. Reddy’s to develop and exclusively commercialize toripalimab in certain countries.
Stay updated with breaking news from Aseptic Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Junshi Biosciences will grant a license to Dr. Reddy’s to develop and exclusively commercialize toripalimab in certain countries.
Transaction includes BPS manufacturing facilities and approximately 1,700 employees in Bloomington, IN and Halle, Germany.
Creates a total of 160,000 ft² of ambient cGMP biostorage capacity with 21,000 pallet locations.
The new space will increase laboratory space dedicated to analytical R&D activities for small molecules by more than 130%.
The two parties plan to collaborate to introduce more high-quality innovative drugs into Southeast Asian markets to achieve joint and long-term development.